Skip to main content

Articles

Page 4 of 59

  1. There is growing evidence that ceramides play a significant role in the onset and progression of non-alcoholic fatty liver disease (NAFLD), a highly prevalent condition in patients with type 2 diabetes associa...

    Authors: Damien Denimal, Sarah Béland-Bonenfant, Jean-Paul Pais-de-Barros, Alexia Rouland, Benjamin Bouillet, Laurence Duvillard, Bruno Vergès and Jean-Michel Petit
    Citation: Cardiovascular Diabetology 2023 22:310
  2. The triglyceride glucose-body mass (TyG-BMI) index is acknowledged as both a reliable indicator of the risk of cardiovascular disease and an accurate surrogate biomarker for evaluating insulin resistance (IR)....

    Authors: Jiahao Dou, Chen Guo, Yawen Wang, Zihe Peng, Ruiyun Wu, Qiangqiang Li, Hong Zhao, Shoufang Song, Xuelu Sun and Jin Wei
    Citation: Cardiovascular Diabetology 2023 22:309
  3. This study aimed to explore the association between the triglyceride-glucose (TyG) index and the risk of in-hospital mortality in critically ill patients with sepsis.

    Authors: Rui Zheng, Songzan Qian, Yiyi Shi, Chen Lou, Honglei Xu and Jingye Pan
    Citation: Cardiovascular Diabetology 2023 22:307
  4. Gut microbiota imbalances have been suggested as a contributing factor to atrial fibrillation (AF), but the causal relationship is not fully understood.

    Authors: Huajie Dai, Tianzhichao Hou, Qi Wang, Yanan Hou, Zheng Zhu, Yijie Zhu, Zhiyun Zhao, Mian Li, Hong Lin, Shuangyuan Wang, Ruizhi Zheng, Yu Xu, Jieli Lu, Tiange Wang, Guang Ning, Weiqing Wang…
    Citation: Cardiovascular Diabetology 2023 22:306
  5. The triglyceride-glucose (TyG) index has been proposed as a potential predictor of adverse prognosis of coronary heart disease (CHD). However, its prognostic value in patients with CHD and hypertension remains...

    Authors: Shiyi Tao, Lintong Yu, Jun Li, Li Huang, Xuanchun Huang, Wenjie Zhang, Zicong Xie, Yuqing Tan and Deshuang Yang
    Citation: Cardiovascular Diabetology 2023 22:305
  6. Triglyceride-glucose index (TyG) has been widely used to predict cardiovascular outcomes. However, it remains unclear whether TyG holds prognostic significance for patients with coronary chronic total occlusio...

    Authors: Yu Yang, Mengqing Ma, Jian Zhang, Shiyu Jin, Dingxin Zhang and Xianhe Lin
    Citation: Cardiovascular Diabetology 2023 22:304
  7. Diabetic cardiomyopathy (DCM) is a major complication of diabetes and a risk factor for cardiovascular disease. Endothelial dysfunction is central to DCM, and endothelial-to-mesenchymal transition (EndMT) is a...

    Authors: Eric Wang, Shali Chen, Honglin Wang, Tori Chen and Subrata Chakrabarti
    Citation: Cardiovascular Diabetology 2023 22:303
  8. Recent type 2 diabetes guidance from the UK’s National Institute for Health and Care Excellence (NICE) proposes offering SGLT2-inhibitor therapy to people with established atherosclerotic cardiovascular diseas...

    Authors: Katherine G. Young, Rhian Hopkins, Beverley M. Shields, Nicholas J. Thomas, Andrew P. McGovern and John M. Dennis
    Citation: Cardiovascular Diabetology 2023 22:302
  9. Sclerostin is an inhibitor of the Wnt/b-catenin pathway, which regulates bone formation, and can be expressed in vascular smooth muscle cells (VSMCs). Type 2 diabetes (T2D) is associated with an increased risk...

    Authors: Sheila González-Salvatierra, Cristina García-Fontana, Jesus Lacal, Francisco Andújar-Vera, Luis Martínez-Heredia, Raquel Sanabria-de la Torre, María Ferrer-Millán, Enrique Moratalla-Aranda, Manuel Muñoz-Torres and Beatriz García-Fontana
    Citation: Cardiovascular Diabetology 2023 22:301
  10. There is uncertainty regarding the role of obesity in type 1 diabetes development. The aim of this systematic review and meta-analysis was to collect and synthesize evidence regarding BMI and the risk of devel...

    Authors: Maya Nitecki, Hertzel C. Gerstein, Yulia Balmakov, Eyal Tsur, Vladislav Babushkin, Tomer Michaeli, Arnon Afek, Orit Pinhas-Hamiel, Tali Cukierman-Yaffe and Gilad Twig
    Citation: Cardiovascular Diabetology 2023 22:300
  11. Circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) is a marker for heart failure in patients with coronary heart disease (CHD) and associated with glycemic abnormalities. Studies on the associat...

    Authors: Tong Yang, Hongmei Zheng, Guangwei Pan, Ruiying Guo, Fengmin Liu, Shengyuan Liu, Shuang Tao, Lin Li, Rongrong Yang and Chunquan Yu
    Citation: Cardiovascular Diabetology 2023 22:299
  12. Uric acid (UA) is an independent prognostic factor for cardiovascular events, but there are no data demonstrating a different risk profile between women and men. Thus, we tested whether UA is associated with a...

    Authors: Maria Perticone, Raffaele Maio, Ermal Shehaj, Simona Gigliotti, Benedetto Caroleo, Edoardo Suraci, Angela Sciacqua, Francesco Andreozzi and Francesco Perticone
    Citation: Cardiovascular Diabetology 2023 22:298
  13. The study aimed to investigate an association of increased liver fibrosis with acute myocardial infarction (AMI), and to investigate the mediating effect of serum follistatin-like protein 3 (FSTL3) on the asso...

    Authors: Wenfei Duan, Ruixiao Shi, Fang Yang, Zhoujunhao Zhou, Lihong Wang, Zhe Huang and Shufei Zang
    Citation: Cardiovascular Diabetology 2023 22:297
  14. We investigated the association of high-sensitivity cardiac troponin (Hs-cTn) with all-cause and cardiovascular mortality in non-diabetic individuals.

    Authors: Lin Liu, Yuen Ting Cheng, Aimin Xu and Bernard M. Y. Cheung
    Citation: Cardiovascular Diabetology 2023 22:296
  15. The study was designed to assess the effect of co-occurrence of diabetes mellitus (DM) and hypertension on the deterioration of left atrioventricular coupling index (LACI) and left atrial (LA) function in comp...

    Authors: Rui Shi, Yi-Ning Jiang, Wen-Lei Qian, Ying-Kun Guo, Yue Gao, Li-Ting Shen, Li Jiang, Xue-Ming Li, Zhi-Gang Yang and Yuan Li
    Citation: Cardiovascular Diabetology 2023 22:295
  16. The PI3K/AKT pathway transduces the majority of the metabolic actions of insulin. In addition to cytosolic targets, insulin-stimulated phospho-AKT also translocates to mitochondria in the myocardium. Mouse mod...

    Authors: Yu-Han Chen, Albert P. Ta, Yumay Chen, Hsiao-Chen Lee, Wenjun Fan, Phang-Lang Chen, Maria C. Jordan, Kenneth P. Roos, Grant R. MacGregor, Qin Yang, Robert A. Edwards, Junfeng Li and Ping H. Wang
    Citation: Cardiovascular Diabetology 2023 22:294
  17. Diabetic kidney disease (DKD) is characterized by the abnormal deposition of oxidized low-density lipoprotein (ox-LDL), which contributes to podocyte damage. Klotho, an aging suppressor that plays a critical r...

    Authors: Wei Jiang, Chun Gan, Xindi Zhou, Qing Yang, Dan Chen, Han Xiao, Lujun Dai, Yaxi Chen, Mo Wang, Haiping Yang and Qiu Li
    Citation: Cardiovascular Diabetology 2023 22:293
  18. The triglyceride-glucose (TyG) index has been suggested as a dependable indicator for predicting major adverse cardiovascular events (MACE) in individuals with cardiovascular conditions. Nevertheless, there is...

    Authors: Enmin Xie, Zixiang Ye, Yaxin Wu, Xuecheng Zhao, Yike Li, Nan Shen, Yanxiang Gao and Jingang Zheng
    Citation: Cardiovascular Diabetology 2023 22:292
  19. Women with gestational diabetes mellitus (GDM) have higher insulin resistance and/or reduced secretion, an increased risk of future diabetes and cardiovascular disease, which may be due to a pathological activ...

    Authors: Dan Yedu Quansah, Antje Horsch, Leah Gilbert, Marc Y. Donath and Jardena J. Puder
    Citation: Cardiovascular Diabetology 2023 22:291
  20. A comprehensive network meta-analysis comparing the effects of individual sodium-glucose cotransporter 2 (SGLT2) inhibitors on patients with and without comorbidities including diabetes mellitus (DM), heart fa...

    Authors: Jui-Yi Chen, Heng-Chih Pan, Chih-Chung Shiao, Min-Hsiang Chuang, Chun Yin See, Tzu-Hsuan Yeh, Yafei Yang, Wen-Kai Chu and Vin-Cent Wu
    Citation: Cardiovascular Diabetology 2023 22:290
  21. Coronary bifurcation lesion, as a complex coronary lesion, is associated with higher risk of long-term poor prognosis than non-bifurcation lesions. The triglyceride-glucose (TyG) index has been shown to predic...

    Authors: Jining He, Sheng Yuan, Chenxi Song, Yanjun Song, Xiaohui Bian, Guofeng Gao and Kefei Dou
    Citation: Cardiovascular Diabetology 2023 22:289
  22. Various studies have indicated that stress hyperglycemia ratio (SHR) can reflect true acute hyperglycemic status and is associated with poor outcomes in patients with acute coronary syndrome (ACS). However, da...

    Authors: Enmin Xie, Zixiang Ye, Yaxin Wu, Xuecheng Zhao, Yike Li, Nan Shen, Yanxiang Gao and Jingang Zheng
    Citation: Cardiovascular Diabetology 2023 22:288
  23. Although recent guidelines advocate for HbA1c target individualization, a comprehensive criterion for patient categorization remains absent. This study aimed to categorize HbA1c variability levels and explore ...

    Authors: Junyu Pei, Xiaopu Wang, Zeyu Pei and Xinqun Hu
    Citation: Cardiovascular Diabetology 2023 22:287
  24. The triglyceride-glucose (TyG) index, which is a reliable substitute indicator for insulin resistance, has been considered an independent risk factor for long-term outcomes in patients with cardiovascular dise...

    Authors: Shutong Dong, Zehao Zhao, Xin Huang, Meishi Ma, Zhiqiang Yang, Chu Fan, Hongya Han, Zhijian Wang, Dongmei Shi and Yujie Zhou
    Citation: Cardiovascular Diabetology 2023 22:286
  25. The study aimed to assess the usefulness of capillaroscopy and photoplethysmography in the search for early vascular anomalies in children with type 1 diabetes.

    Authors: Klaudia Bogusz-Górna, Adriana Polańska, Aleksandra Dańczak-Pazdrowska, Ryszard Żaba, Marta Sumińska, Piotr Fichna and Andrzej Kędzia
    Citation: Cardiovascular Diabetology 2023 22:285
  26. The Triglyceride-glucose (TyG) index, as a surrogate marker of insulin resistance, is independently associated with the severity of coronary artery lesions and the prognosis of coronary heart disease. The inve...

    Authors: Qiang Chen, Shiqiang Xiong, Zhen Zhang, Xiuqiong Yu, Yingzhong Chen, Tao Ye, Siqi Yang, Lingyao Qi, Xu Chen, Hanxiong Liu, Jingang Zheng and Lin Cai
    Citation: Cardiovascular Diabetology 2023 22:284
  27. Early diagnosis and treatment effectiveness of early-onset coronary artery disease (EOCAD) are crucial, and non-invasive predictive biomarkers are needed for young adults. We aimed to evaluate the usefulness o...

    Authors: Shalaimaiti Shali, Lingfeng Luo, Kang Yao, Xiangdong Sun, Hongyi Wu, Shuning Zhang, Lili Xu, Wei Gao, Jianxuan Li, Juying Qian, Yan Zheng, Yuxiang Dai and Junbo Ge
    Citation: Cardiovascular Diabetology 2023 22:283
  28. It is unclear to what extent genetics explain the familial clustering and the co-occurrence of distinct cardiometabolic disorders in the general population. We therefore aimed to quantify the familial (co-)agg...

    Authors: Rima D. Triatin, Zekai Chen, Alireza Ani, Rujia Wang, Catharina A. Hartman, Ilja M. Nolte, Chris H. L. Thio and Harold Snieder
    Citation: Cardiovascular Diabetology 2023 22:282
  29. Among patients with acute coronary syndrome and percutaneous coronary intervention, stress hyperglycemia ratio (SHR) is primarily associated with short-term unfavorable outcomes. However, the relationship betw...

    Authors: Jin Liu, Yang Zhou, Haozhang Huang, Rui Liu, Yu Kang, Tingting Zhu, Jielan Wu, Yuwei Gao, Yuqi Li, Chenyang Wang, Shiqun Chen, Nianjin Xie, Xueyan Zheng, Ruilin Meng, Yong Liu, Ning Tan…
    Citation: Cardiovascular Diabetology 2023 22:281
  30. Diabetes mellitus (DM) accelerates the progression of aortic stenosis (AS), but how their underlying molecular mechanisms interact is not clear. Moreover, whether DM contributes to clinically relevant sex-diff...

    Authors: Ernesto Martín-Núñez, Miriam Goñi-Olóriz, Lara Matilla, Mattie Garaikoetxea, Laura Mourino-Alvarez, Adela Navarro, Amaya Fernández-Celis, Ibai Tamayo, Alicia Gainza, Virginia Álvarez, Rafael Sádaba, María G. Barderas, Eva Jover and Natalia López-Andrés
    Citation: Cardiovascular Diabetology 2023 22:280
  31. The association between the triglyceride-glucose (TyG) index and mortality in cardiovascular disease (CVD) patients with diabetes or pre-diabetes remains unclear. This study aimed to investigate the relationsh...

    Authors: Qin Zhang, Shucai Xiao, Xiaojuan Jiao and Yunfeng Shen
    Citation: Cardiovascular Diabetology 2023 22:279
  32. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown promise in reducing the risk of atrial fibrillation (AF). However, the results are controversial and the underlying metabolic mechanism remains uncl...

    Authors: Jiang Li, Yuefeng Yu, Ying Sun, Bowei Yu, Xiao Tan, Bin Wang, Yingli Lu and Ningjian Wang
    Citation: Cardiovascular Diabetology 2023 22:278
  33. In recent years, several novel agents have become available to treat individuals with type 2 diabetes (T2D), such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i), tirzepatide, which is a dual glucose-de...

    Authors: Antonio Ceriello, Helena W. Rodbard, Tadej Battelino, Frank Brosius, Francesco Cosentino, Jennifer Green, Linong Ji, Monika Kellerer, Susan Koob, Mikhail Kosiborod, Nebojsa Lalic, Nikolaus Marx, T. Prashant Nedungadi, Christopher G. Parkin, Lars Rydén, Wayne Huey-Herng Sheu…
    Citation: Cardiovascular Diabetology 2023 22:277
  34. O-GlcNAcylation is the enzymatic addition of a sugar, O-linked β-N-Acetylglucosamine, to the serine and threonine residues of proteins, and is abundant in diabetic conditions. We have previously shown that O-G...

    Authors: Chidinma A Okolo, Ei-Phyo Khaing, Valeria Mereacre, Rachel S Wallace, Michelle L Munro, Jeffrey R Erickson and Peter P. Jones
    Citation: Cardiovascular Diabetology 2023 22:276
  35. The stress hyperglycemia ratio (SHR) has demonstrated a noteworthy association with unfavorable cardiovascular clinical outcomes and heightened in-hospital mortality. Nonetheless, this relationship in critical...

    Authors: Le Li, Minghao Zhao, Zhuxin Zhang, Likun Zhou, Zhenhao Zhang, Yulong Xiong, Zhao Hu and Yan Yao
    Citation: Cardiovascular Diabetology 2023 22:275
  36. Evidence on the associations between baseline stromal cell-derived factor (SDF)-1 and clinical outcomes in acute ischemic stroke patients is lacking. The present study aimed to examine the relationship between...

    Authors: Shoujiang You, Hongyu Chen, Mengyuan Miao, Jigang Du, Bizhong Che, Tan Xu, Chun-Feng Liu, Yonghong Zhang, Jiang He, Xiaoyan Zhong, Yongjun Cao and Chongke Zhong
    Citation: Cardiovascular Diabetology 2023 22:274
  37. This study aimed to reveal the prevalence of sodium-glucose co-transporter 2 (SGLT2) inhibitor treatment and its association with restenosis risk in patients with diabetes mellitus undergoing endovascular ther...

    Authors: Mitsuyoshi Takahara, Yoshimitsu Soga, Masahiko Fujihara, Osamu Iida and Daizo Kawasaki
    Citation: Cardiovascular Diabetology 2023 22:273
  38. Effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus long-acting insulins (LAIs) on preventing progressive chronic kidney outcomes is uncertain for type 2 diabetes (T2D) patients requir...

    Authors: Zi-Yang Peng, Chun-Ting Yang, Wei-Hung Lin, Wen-Yu Yao, Huang-Tz Ou and Shihchen Kuo
    Citation: Cardiovascular Diabetology 2023 22:272
  39. There is mounting evidence that the Mediterranean diet prevents type 2 diabetes, but little is known about the role of Mediterranean lifestyles other than diet and among non-Mediterranean populations. This wor...

    Authors: Javier Maroto-Rodriguez, Rosario Ortolá, Adrián Carballo-Casla, Víctor Iriarte-Campo, Miguel Ángel Salinero-Fort, Fernando Rodríguez-Artalejo and Mercedes Sotos-Prieto
    Citation: Cardiovascular Diabetology 2023 22:271
  40. Previous studies have reported an association between a significant decline in estimated glomerular filtration rate (eGFR) over time and an increased risk of cardiovascular disease (CVD). This study aimed to i...

    Authors: Azra Ramezankhani, Fereidoun Azizi and Farzad Hadaegh
    Citation: Cardiovascular Diabetology 2023 22:270
  41. Pharmacological post-MI treatment is routinely initiated at intensive/cardiac care units. However, solid evidence for an early start of these therapies is only available for dual platelet therapy and statins, ...

    Authors: Dirk von Lewinski, Ewald Kolesnik, Faisal Aziz, Martin Benedikt, Norbert J. Tripolt, Markus Wallner, Peter N. Pferschy, Friederike von Lewinski, Nora Schwegel, Rury R. Holman, Abderrahim Oulhaj, Deddo Moertl, Jolanta Siller-Matula and Harald Sourij
    Citation: Cardiovascular Diabetology 2023 22:269
  42. Previous studies have reported that inflammatory responses can promote the onset of cardiovascular diseases; however, its association with cardiac conduction disorders remains unclear. The present community-ba...

    Authors: Lili Wu, Meimei Wu, Dandan Zhao, Shuohua Chen, Guodong Wang, Lina Xu, Yujing Wang, Lina An, Shouling Wu, Congliang Miao and Jiang Hong
    Citation: Cardiovascular Diabetology 2023 22:268
  43. Evidence regarding the neutrophil–lymphocyte ratio (NLR) and mortality risk in diabetes patients is scarce. This study investigated the relationship of the NLR with all-cause and cardiovascular mortality risk ...

    Authors: Gaiying Dong, Man Gan, Shilin Xu, Yanlin Xie, Ming Zhou and Liangliang Wu
    Citation: Cardiovascular Diabetology 2023 22:267
  44. The impact of Type 2 Diabetes (T2D) on the outcomes of heart transplantation (HT) has not yet been clearly established. The objectives of this study were to examine the trends in the prevalence of T2D among in...

    Authors: Ana Lopez-de-Andres, Rodrigo Jiménez-García, Valentin Hernández-Barrera, David Carabantes-Alarcon, Jose J. Zamorano-Leon, Ricardo Omaña Palanco, Jose L. del-Barrio, Javier de-Miguel-Díez, Jose M. de-Miguel-Yanes and Natividad Cuadrado-Corrales
    Citation: Cardiovascular Diabetology 2023 22:266
  45. Diabetes poses a significant threat to human health. There is a lack of large-scale cohort studies to explore the association between mortality risk and indicators beyond blood glucose monitoring in diabetic p...

    Authors: Fan Yang, Mingsi Wang, Yuzhu Chen, Jianjun Wu and Yilan Li
    Citation: Cardiovascular Diabetology 2023 22:265
  46. Frailty is an age-related geriatric syndrome that leads to a series of clinically negative events. A better understanding of the factors associated with frailty assists in preventing its progression. The trigl...

    Authors: Yin Yuan, Simiao Chen, Chunjin Lin, Xiaoming Huang, Siyang Lin, Feng Huang and Pengli Zhu
    Citation: Cardiovascular Diabetology 2023 22:264
  47. The impact of insulin resistance on the prognosis of heart failure with preserved ejection fraction (HFpEF) remains unknown. This study aimed to investigate the association between the triglyceride-glucose (Ty...

    Authors: Qing Zhou, Jie Yang, Hongyi Tang, Zexuan Guo, Wenyue Dong, Yiting Wang, Xiangbin Meng, Kuo Zhang, Wenyao Wang, Chunli Shao, Xinwei Hua and Yi-Da Tang
    Citation: Cardiovascular Diabetology 2023 22:263
  48. Several large observational prospective studies have reported a protection by the traditional Mediterranean diet against type 2 diabetes, but none of them used yearly repeated measures of dietary intake. Repea...

    Authors: Miguel A. Martínez-González, Pedro Montero, Miguel Ruiz-Canela, Estefanía Toledo, Ramón Estruch, Enrique Gómez-Gracia, Jun Li, Emilio Ros, Fernando Arós, Alvaro Hernáez, Dolores Corella, Miquel Fiol, José Lapetra, Lluis Serra-Majem, Xavier Pintó, Montse Cofán…
    Citation: Cardiovascular Diabetology 2023 22:262
  49. Patients with type 2 diabetes have an increased risk of death and cardiovascular events and people with diabetes or prediabetes have been found to have increased atherosclerotic burden in the coronary and caro...

    Authors: Carl Johan Östgren, Julia Otten, Karin Festin, Oskar Angerås, Göran Bergström, Kerstin Cederlund, Gunnar Engström, Maria J. Eriksson, Mats Eriksson, Tove Fall, Anders Gummesson, Emil Hagström, Urban Hellman, Stefan K. James, Tomas Jernberg, Johan Kihlberg…
    Citation: Cardiovascular Diabetology 2023 22:261

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions